Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The treatment of vancomycin-resistant enterococcal (VRE) bacteraemia remains challenging. Daptomycin is a new antibiotic with bactericidal activity against VRE, but available clinical data are limited. METHODS: A retrospective study was performed on 98 adult patients with VRE bacteraemia admitted to two hospitals between September 2003 and December 2007 to compare the efficacy of daptomycin with that of linezolid. Multivariable analyses were performed to compare the microbiological and clinical outcomes of both groups. RESULTS: Out of 98 patients with VRE bacteraemia, 68 were treated with linezolid and 30 with daptomycin. Univariate analyses showed no significant differences between the groups regarding baseline demographic and clinical characteristics, severity of illness and co-morbidity. Daptomycin was associated with a trend towards a higher mortality rate (26.7% versus 20.6%), longer median duration of bacteraemia (3 days versus 2 days) and higher relapse rate (6.7% versus 2.9%), but these differences did not reach statistical significance (P > 0.2). Microbiological cure rates were 90% for the daptomycin group and 88.2% for the linezolid group (P = 0.92). CONCLUSIONS: Despite a trend towards worse outcomes, daptomycin was as effective as linezolid in treating VRE bacteraemia. A randomized clinical trial is needed to confirm these results.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mave et al 203 reported cure in 2 of 3 patients with E faecium IE with linezolid.”
In the citing paper
“The number of cases of vancomycin-resistant Enterococcus bacteremia was too small to draw significant conclusions about treatment response rates.”
In the citing paper
“Mave et al 203 compared daptomycin with linezolid for vancomycin-resistant Enterococcus bacteremia.Five patients had E faecium IE; 1 of 2 daptomycin-treated patients and 2 of 3 linezolid-treated patients survived.”
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“Vancomycin-resistant enterococci (VRE) emerged in the late 1980s and resistance to vancomycin is now found in 60% of Enterococcus faecium isolates causing nosocomial bloodstream infections (BSIs) encountered in US healthcare institutions.(1) Two different meta-analyses have shown that vancomycin resistance is an indep…”
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
DiazGranados, C. A., Zimmer, S. M., Mitchel, K., & Jernigan, J. A. (2005) · Clinical Infectious Diseases · doi:10.1086/430909 · Cited by 459 · cited 2×
“Vancomycin-resistant enterococci (VRE) emerged in the late 1980s and resistance to vancomycin is now found in 60% of Enterococcus faecium isolates causing nosocomial bloodstream infections (BSIs) encountered in US healthcare institutions.1 Two different meta-analyses have shown that vancomycin resistance is an indepen…”
Hematologic Effects of Linezolid: Summary of Clinical Experience
Gerson, S. L., Kaplan, S. L., Bruss, J. B., Le, V., Arellano, F. M., Hafkin, B., & Kuter, D. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2723-2726.2002 · Cited by 443
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Prevention and Treatment of Cancer-Related Infections
Baden, L. R., Bensinger, W., Angarone, M., Casper, C., Dubberke, E. R., Freifeld, A. G., Garzon, R., Greene, J. N., Greer, J. P., Ito, J. I., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0146 · Cited by 368
Enterococcal Infection—Treatment and Antibiotic Resistance
Kristich, C. J., Rice, L. B., & Arias, C. A. (2014) · Europe PMC (PubMed Central) · Cited by 315
Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?
Cattoir, V., & Leclercq, R. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks469 · Cited by 234
Mishra, N. N., Bayer, A. S., Tran, T. T., Shamoo, Y., Mileykovskaya, E., Dowhan, W., Guan, Z., & Arias, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043958 · Cited by 168
Balli, E. P., Venetis, C. A., & Miyakis, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01289-13 · Cited by 167
Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization
Cheah, A. L. Y., Spelman, T. D., Liew, D., Peel, T. N., Howden, B. P., Spelman, D., Grayson, M. L., Nation, R. L., & Kong, D. C. M. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12132 · Cited by 162
Britt, N. S., Potter, E. M., Patel, N., & Steed, M. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ444 · Cited by 142
Antibiotic resistance inEnterococcus faeciumclinical isolates
Cattoir, V., & Giárd, J.-C. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.870886 · Cited by 132
Daptomycin: A Review of Properties, Clinical Use, Drug Delivery and Resistance
Vilhena, C., & Bettencourt, A. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557511209030202 · Cited by 126
Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms
Sy, C.-L., Chen, P., Cheng, C.-W., Huang, L.-J., Wang, C.-H., Chang, T., Chang, Y., Chang, C.-J., Hii, I.-M., Hsu, Y., et al. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.02.001 · Cited by 123
Chuang, Y., Wang, J., Lin, H., & Chang, S. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0687-9 · Cited by 117
Shukla, B. S., Shelburne, S. A., Reyes, K., Kamboj, M., Lewis, J. D., Rincón, S., Reyes, J., Carvajal, L. P., Panesso, D., Sifri, C. D., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw173 · Cited by 109
Self-citationHall, A. D., Steed, M. E., Arias, C. A., Murray, B. E., & Rybak, M. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06439-11 · Cited by 101
A potential role for daptomycin in enterococcal infections: what is the evidence?
Canton, R., Ruiz-Garbajosa, P., Chaves, R. L., & Johnson, A. P. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq087 · Cited by 94
Whang, D. W., Miller, L. G., Partain, N. M., & McKinnell, J. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-13 · Cited by 95
Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
Casapao, A. M., Kullar, R., Davis, S. L., Levine, D. P., Zhao, J. J., Potoski, B. A., Goff, D. A., Crank, C. W., Segreti, J., Sakoulas, G., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00526-13 · Cited by 93
Chuang, Y., Lin, H.-Y., Chen, P., Lin, C.-H., Wang, J., & Chang, S. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.07.018 · Cited by 86
Twilla, J. D., Finch, C. K., Usery, J. B., Gelfand, M. S., Hudson, J. Q., & Broyles, J. E. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.994 · Cited by 74
What’s New in the Treatment of Enterococcal Endocarditis?
Nigo, M., Munita, J. M., Arias, C. A., & Murray, B. E. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0431-z · Cited by 59
Vancomycin-Resistant Enterococcal Bacteremia Pharmacotherapy
Patel, R., & Gallagher, J. C. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014556879 · Cited by 58
Daptomycin: pharmacology and clinical use
Kosmidis, C., & Levine, D. P. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003598893 · Cited by 57
The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution
Reinseth, I. S., Ovchinnikov, K. V., Tønnesen, H. H., Carlsen, H., & Diep, D. B. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09618-6 · Cited by 56
Kraft, S. L., Mackler, E. R., Schlickman, P., Welch, K. B., & DePestel, D. D. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-1038-z · Cited by 52
Zhao, M., Liang, L., Ji, L., Chen, D., Zhang, Y., Zhu, Y., & Patel, K. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.06.010 · Cited by 47
McKinnell, J. A., Patel, M., Shirley, R. M., Kunz, D. F., Moser, S. A., & Baddley, J. W. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810002475 · Cited by 46
Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci
Munita, J. M., Murray, B. E., & Arias, C. A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.08.002 · Cited by 45
Shi, C., Jin, W., Xie, Y., Zhou, D., Xu, S., Li, Q., & Lin, N. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.10.008 · Cited by 42
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King, E. A., McCoy, D., Desai, S., Nyirenda, T. L., & Bicking, K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr255 · Cited by 41
Therapeutic options for vancomycin-resistant enterococcal bacteremia
Barber, K. E., King, S. T., Stover, K. R., & Pogue, J. M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1001839 · Cited by 39
Britt, N. S., Potter, E. M., Patel, N., & Steed, M. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02216-16 · Cited by 38
Current management of bloodstream infections
Rodríguez‐Baño, J., de Cueto, M., Retamar, P., & Gálvez-Acebal, J. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.49 · Cited by 37
Narayanan, N., Rai, R., Vaidya, P., Desai, A., Bhowmick, T., & Weinstein, M. P. (2019) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936119828964 · Cited by 34
Hayakawa, K., Martin, E. T., Gudur, U. M., Marchaim, D., Dalle, D., Alshabani, K., Muppavarapu, K. S., Jaydev, F., Bathina, P., Sundaragiri, P. R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02943-14 · Cited by 31
Cerón, I., Munoz, P., Marín, M., Segado, A., Roda, J., Valerio, M., Bouza, E., Bermejo, J., Bouza, E., Eworo, A., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku004 · Cited by 29
Murray, B. E., Arias, C. A., & Nannini, E. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00030-8 · Cited by 27
Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan
Chou, C.-H., Lee, N., Lee, H., Chang, C., Lee, C., & Ko, W. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2011.11.005 · Cited by 25
Raven, K. E., Gouliouris, T., Parkhill, J., & Peacock, S. J. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01520-17 · Cited by 23
Treatment strategies for infective endocarditis
Chopra, T., & Kaatz, G. W. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903496430 · Cited by 22
Neonatal Septicaemia Caused by Vancomycin Resistant Enterococcus Faecium -A Case Report
Shantala, G., Nagarathnamma, T., Dr, P., Tr, H., & Karthik, R. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/10284.5220 · Cited by 18
Suleyman, G., & Zervos, M. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1127349 · Cited by 18
Rana, S. W., Kumar, A., Walia, S. K., Berven, K., Cumper, K., & Walia, S. K. (2010) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04860.x · Cited by 17
Antimicrobial resistance in internal medicine wards
Menichetti, F., & Tagliaferri, E. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0828-3 · Cited by 13
Bio, L. L., Perez, M. E., MacDougall, C., & Gallagher, J. C. (2011) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31822b7f6e · Cited by 13
Patel, K., Kabir, R., Ahmad, S., & Allen, S. L. (2014) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155214556523 · Cited by 13
Shukla, B. S., Gauthier, T. P., Correa, R., Smith, L. B., & Abbo, L. M. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9825-5 · Cited by 11
ENTEROCOCCUS RESISTENTE A VANCOMICINA (VRE): PERFIL GERAL
Santos, M. A. D., Paiva, I. C. D., & Andrade, E. G. D. S. A. E. G. D. S. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.5281/zenodo.4613827 · Cited by 9
Recommendations for the diagnosis and treatment of bone marrow form of acute radiation syndrome
Samoylov, А. S., Konchalovsky, M. V., Bushmanov, A. Y., Galstyan, I. A., Nugis, V. Y., Davtyan, A., Kolganova, L. R., Metlyaeva, N. A., & Torubarov, F. S. (2023) · Гематология и трансфузиология · doi:10.35754/0234-5730-2023-68-1-98-128 · Cited by 7
Suleyman, G., Mahan, M., & Zervos, M. (2017) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000482 · Cited by 7
Short course of antimicrobial treatment for uncomplicated enterococcal bacteremia
Zimmermann, V., Fourré, N., Senn, L., Guery, B. P., & Papadimitriou‐Olivgeris, M. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05348-6 · Cited by 6
Kraft, S. L., Mackler, E. R., Schlickman, P., Welch, K., & DePestel, D. D. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1440-9 · Cited by 6
Garnacho‐Montero, J., Amaya‐Villar, R., Grande, M. L. G., Gómez-Coronado, V. J., Ramos, L. L., Vázquez, A. L., Pellús, A. M., Laderas, J. C. P., Camerino, R. S., Mora, J. P., et al. (2011) · PubMed · Cited by 4
Trikha, R., Greig, D. E., Sekimura, T. K., Geiger, E. J., Wessel, L. E., Eċkardt, J. J., & Bernthal, N. M. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27428 · Cited by 4
Oral antimicrobial options for vancomycin-resistant Enterococcus isolates in urine culture
Mohammed, R. S. D., & Yeung, E. Y. H. (2024) · Bladder · doi:10.14440/bladder.2024.0016 · Cited by 4
de Colombia, U. P. Y. T., Caicedo, Y., Gómez, J. A. U., http://aprendeenlinea.udea.edu.co/revistas/index.php/iatreia/article/view/24199/20783938, Fernández-Niño, D. S., de Colombia, U. P. Y. T., Guerra, S. A. G., de Colombia, U. P. Y. T., Méndez-Fandiño, Y., & de Colombia, U. P. Y. T. (2017) · IATREIA · doi:10.17533/udea.iatreia.v30n1a01 · Cited by 4
Tratamiento con daptomicina en pacientes con bacteriemia
Llinares, P., & Iribarren, J. A. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(12)70067-8 · Cited by 2
Safety and Efficacy of Daptomycin in the Treatment of Gram-Positive Pathogens
Kelesidis, T. (2011) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s6122 · Cited by 1
Enterococcal Neonatal Septicemia
Sharma, M., Yadav, A., & Yadav, A. D. S. (2012) · International Journal of Pharma and Bio Sciences · Cited by 1
Leather, H. L., & Wingard, J. R. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch85 · Cited by 1
Multiresistente grampositive Erreger (MRSA, VRE)
Kern, J. M. (2015) · Springer eBooks · doi:10.1007/978-3-642-54676-1_549-1 · Cited by 1
Sucesso no controle da transmissão de Enterococcus spp. em um hospital universitário brasileiro
Nascimento, F. A. F. R. (2011) · doi:10.47749/t/unicamp.2011.795453
Present and Emerging Therapies for the Treatment of Drug-resistant Infections: Focus on Linezolid
Souli, M. (2010) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s1571
Balmer, P. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-11737
Otsuka, M., Kharfan‐Dabaja, M. A., Wetzstein, G. A., Quilitz, R. E., Sandin, R. L., & Greene, J. N. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e3182639da4
Bal, A. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00201-2
Haslam, D. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00179-2
Safwat, N. A., Elshimy, R. M., Hassanin, S. O., Elmanakhly, A. R., Noaf, A. N., Mansour, A. T., Alshehri, F., Alhomrani, M., Alamri, A. S., & Bendary, M. M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1493769
Metadata
- Authors
- Mave, V., Garcia-Diaz, J., Islam, T., & Hasbun, R.
- Affiliations
- Tulane University (US)
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Hasbun, R.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05-07
- Volume
- 64
- Issue
- 1
- Pages
- 175-180
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2170330952
- Semantic Scholar
- 187b1296174d179f0623afc59e2c538690a24325
- Cited by
- 65
- References
- 27
- Citations by year
- 2025: 2 · 2023: 2 · 2022: 2 · 2019: 3 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 11 · 2013: 5 · 2012: 11
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- vancomycin-resistant enterococci, bacteremia, daptomycin, linezolid, antibiotic efficacy comparison, mortality, relapse, microbiological cure, bactericidal activity
- MeSH terms
- Linezolid, Acetamides, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Female, Humans, Male, Middle Aged, Retrospective Studies, Bacteremia, Treatment Outcome, Gram-Positive Bacterial Infections, Enterococcus, Daptomycin, Vancomycin Resistance, Oxazolidinones, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.